)
CorMedix (CRMD) investor relations material
CorMedix Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 23, 2026, with voting available online, by mail, or virtually.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of seven directors is on the ballot.
Advisory vote on executive compensation for 2025.
Ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending December 31, 2026.
Ratification of Certificate of Designation Amendments.
Amendments to the Charter for technical changes and to update approval processes for preferred stock amendments.
Charter amendment to designate exclusive forums for certain claims.
Charter amendment to limit certain officers' personal liability for monetary damages.
Proposal to allow adjournment of the meeting if more time is needed for voting on key proposals.
Board of directors and corporate governance
Seven nominees listed for election to the board.
Board recommends voting in favor of all proposals.
- Proxy details robust 2025 results, major governance updates, and key proposals for shareholder approval.CRMD
Proxy filing29 Apr 2026 - Diversified portfolio and late-stage pipeline drive growth and key clinical milestones.CRMD
Investor Day 202620 Apr 2026 - Proxy outlines 2026 meeting proposals, governance updates, and strong 2025 financial results.CRMD
Proxy filing17 Apr 2026 - REZZAYO phase III data and DefenCath reimbursement reset are key near-term catalysts.CRMD
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - REZZAYO phase III data and DefenCath expansion drive growth amid a diversified, lean operation.CRMD
The Citizens Life Sciences Conference 202611 Mar 2026 - Diversified specialty pharma advancing REZZAYO and DefenCath, with strong growth catalysts ahead.CRMD
Leerink Global Healthcare Conference 202610 Mar 2026 - Strong growth, diversified portfolio, and expanding pipeline drive sustained value creation.CRMD
Corporate presentation10 Mar 2026 - Q4 2025 net revenue hit $128.6M, with strong profit and robust 2026 outlook.CRMD
Q4 20255 Mar 2026 - DefenCath's rapid commercial success drives profitability and expansion in dialysis and beyond.CRMD
The Citizens JMP Life Sciences Conference 20253 Feb 2026
Next CorMedix earnings date
Next CorMedix earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)